News

BIO-CAT Gains Organic Certification to Meet the Growing Demands of Consumers

As consumer demand for clean-label, organic, and non-GMO products continues to surge, the pressure is mounting on ingredient suppliers to meet stringent certification standards and scale production accordingly.

As the “food as medicine” movement gains traction and shoppers report increasing their purchases of natural (23%) and organic (22%) products over the last six months, the message is clear: the future of food is clean, and suppliers must rise to the occasion—or risk being left behind*.

According to industry research, sales of natural, organic, and functional products grew by 6.6%, while conventional product sales declined by 0.2%**. This growth is largely driven by consumers prioritizing health, transparency, and sustainability. Organic and non-GMO certifications remain the top two attributes driving purchasing decisions—with 65% of shoppers stating they are more likely to buy a product that carries either the USDA Organic or Non-GMO Project Verified seal***.

This consumer demand is now aligning with policy, as the White House Administration echoes the need for increased access to organic options. “All Americans deserve access to clean, organic, healthy food for our families and children,” states the MAHA Action website. “Major food companies need to take accountability and responsibility for the ingredients that they put in our food and how they market their products to consumers.”

However, meeting this rapidly growing demand is no easy feat. Becoming organic certified requires a rigorous inspection process and adherence to strict federal standards prohibiting the use of synthetic pesticides, GMOs, and growth hormones. As brands shift toward clean formulations, ingredient suppliers are being called upon to deliver at scale—without compromising on integrity or quality.

Two companies rising to meet this challenge are BIO-CAT, Inc. (Troy, VA) and BIO-CAT Microbials, LLC (Shakopee, MN), both of which have successfully achieved Organic Certification through QAI (Quality Assurance International), a leading certification body under the USDA National Organic Program. This certification also extends to their branded products, OPTIZIOME P3 HYDROLYZER® from BIO-CAT, Inc. and OPTIBIOME BS50® from BIO-CAT Microbials, Inc.

“BIO-CAT is committed to producing top-quality products for our customers,” said Robert Boyd, Director of Compliance for both companies. “Achieving organic certification for our facilities is another level of quality that we have implemented into our operations, as well as for the ingredients we produce.”

As the leader in enzyme solutions and probiotic strain development and fermentation, BIO-CAT and BIO-CAT Microbials understand that this certification is critical for both their customers and to continue to demonstrate their leadership role in the industry. “BIO-CAT and BIO-CAT Microbials are proud to support the growing natural product movement with a robust portfolio of non-GMO enzymes and non-GMO microbials” stated Chris Schuler, CEO & Founder of BIO-CAT and BIO-CAT Microbials. “I look forward to our team sharing this information with the industry at Vitafoods Europe in Barcelona this week.”

Learn more here.

Recent News

05/13/2026

BRAINBox Solutions Announces Appointment of Richard H. Noel as Chief Product and Commercial Officer

BRAINBox Solutions today announced the appointment of Richard H. Noel to the newly created position of Chief Product and Commercial Officer. Richard brings more than 10 years of experience in molecular and point-of-care diagnostics, at Roche Diagnostics, LumiraDx, and bioMérieux. “Richard, whose expertise spans market analytics, global product management, and senior commercial leadership, has established

05/12/2026

Phlow Corp. Appoints Tim Mayleben Chief Executive Officer as Co-Founder Dr. Eric Edwards Transitions to Chairman Emeritus and Strategic Advisor

Phlow Corp., a leading American advanced pharmaceutical contract development and manufacturing organization (CDMO), today announced that Tim Mayleben has been appointed Chief Executive Officer, effective immediately. Eric Edwards, M.D., Ph.D., Phlow’s co-founder and former CEO, has transitioned to the role of Chairman Emeritus and Strategic Advisor to the CEO and Board of Directors. The leadership

05/09/2026

NIRSense Supports the US Army in the Indo-Pacific with Tissue Oxygenation Assessment for Battlefield Casualty Care at Balikatan-26

NIRSense, Inc. today announced its participation in Balikatan-26, supporting the US Army Pacific (USARPAC)’s 18th Theater Medical Command (18th TMC) as they evaluate advanced approaches to battlefield casualty assessment using portable tissue oxygen saturation (StO₂) monitoring. Balikatan, meaning “shoulder-to-shoulder,” is the longstanding U.S.-Philippine bilateral exercise designed to strengthen interoperability and regional readiness through combined operations